Motoaki Mitsuki
PMDA-Pharmaceuticals and Medical Devices Agency
Joined PMDA in February 2008
From February 2008 to July 2011: Office of New Drag IV
From August 2011 to now: Office of Vaccine and Blood Products
From February 2008 to July 2011: Office of New Drag IV
From August 2011 to now: Office of Vaccine and Blood Products
Appearances
DateDecember 8, 2021In this session, the strategies/approaches to address the challenges of accelerated CMC development for new modalities will be discussed, based on recent experiences with fast-to–market of vaccines and therapeutics for COVID-19…Session Chairs
NIHS-National Institute of Health SciencesAstraZenecaSpeakers
PMDA-Pharmaceuticals and Medical Devices AgencyPfizer, Inc.AstraZenecaRegeneron Pharmaceuticals, Inc.Genentech, a Member of the Roche GroupF. Hoffmann-La Roche Ltd.
DateDecember 8, 2021In this session, the strategies/approaches to address the challenges of accelerated CMC development for new modalities will be discussed, based on recent experiences with fast-to–market of vaccines and therapeutics for COVID-19…Speakers
PMDA-Pharmaceuticals and Medical Devices AgencyPfizer, Inc.AstraZenecaRegeneron Pharmaceuticals, Inc.Genentech, a Member of the Roche GroupF. Hoffmann-La Roche Ltd.Session Chairs
NIHS-National Institute of Health SciencesAstraZeneca
